3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Skin Neoplasms
1
Rectal Diseases
1
Neoplasms
1
Hemorrhage
1
Endometriosis
1
Dysplastic Nevus Syndrome
1
Diverticulitis
1
Crohn Disease
1
Constipation
1
Colonic Diseases
1
Colitis, Ulcerative
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Interventions
HhAntag691
18
Imiquimod
10
sonidegib
8
Photochemotherapy
7
1-phenyl-3,3-dimethyltriazene
6
methyl 5-aminolevulinate
4
Surgical Procedures, Operative
4
Biopsy
4
Aminolevulinic Acid
4
cemiplimab
3
Mohs Surgery
3
Microscopy, Confocal
3
Itraconazole
3
IPI-926
3
3-ingenyl angelate
3
tazarotene
2
Microarray Analysis
2
Laser Therapy
2
Gene Expression Profiling
2
Eflornithine
2
Drug Evaluation
2
Acitretin
2
tozuleristide
1
teriflunomide
1
talimogene laherparepvec
1
silmitasertib
1
remetinostat
1
pembrolizumab
1
gusacitinib
1
green tea extract polyphenone E
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Basal Cell
×
Sutures
×
Clear all
NCT00586040
2009-04-10
PTB
Massachusetts General Hospital
Phase 2
Completed
40 enrolled